LRN Stock Analysis: Stride | NYSE
Education & Training Services | NYSE, USA | Market Cap: 3.766m USD | 12M Return: -34.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 69.7M
EPS Trend: 99.2%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Stride, Inc. (NYSE: LRN) is a U.S.-based provider of online curriculum, software platforms, and educational services serving K-12 and adult learners across public schools, school districts, charter boards, private schools, consumers, employers, and government agencies. The company offers an integrated package of products and professional support for virtual and blended public schools, learning software for traditional schools and districts, individual online courses in core subjects, and tuition-based private schools. It also operates career learning programs through its Galvanize, Tech Elevator, and MedCerts brands, delivering skills training in software engineering, healthcare, and medical fields to adult learners, along with staffing and talent development services for employers.
Formerly known as K12 Inc., the company rebranded as Stride, Inc. in December 2020 and is headquartered in Reston, Virginia. Stride operates within the Education Services sub-industry of the Consumer Discretionary sector, an area that has expanded with the broader adoption of digital and remote learning models and growing employer demand for workforce-focused, skills-based training.
- K-12 online enrollment growth drives core segment revenue
- Career learning expansion through MedCerts and Tech Elevator acquisitions
- State regulation and funding cuts threaten online charter enrollment
| Net Income: 308.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.23 > 1.0 |
| NWC/Revenue: 58.19% < 20% (prev 54.40%; Δ 3.80% < -1%) |
| CFO/TA 0.18 > 3% & CFO 429.4m > Net Income 308.1m |
| Net Debt (-128.6m) to EBITDA (535.7m): -0.24 < 3 |
| Current Ratio: 6.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.6m) vs 12m ago -3.20% < -2% |
| Gross Margin: 38.34% > 18% (prev 39.08%; Δ -0.73% > 0.5%) |
| Asset Turnover: 108.9% > 50% (prev 103.5%; Δ 5.42% > 0%) |
| Interest Coverage Ratio: 35.63 > 6 (EBIT TTM 412.8m / Interest Expense TTM 11.6m) |
| A: 0.60 (Total Current Assets 1.76b - Total Current Liabilities 283.2m) / Total Assets 2.45b |
| B: 0.45 (Retained Earnings 1.10b / Total Assets 2.45b) |
| C: 0.18 (EBIT TTM 412.8m / Avg Total Assets 2.33b) |
| D: 2.04 (Book Value of Equity 1.64b / Total Liabilities 805.0m) |
| Altman-Z'' = 8.76 = AAA |
| DSRI: 1.10 (Receivables 854.9m/699.8m, Revenue 2.54b/2.29b) |
| GMI: 1.02 (GM 39.08% / 38.34%) |
| AQI: 0.93 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.11 (Revenue 2.54b / 2.29b) |
| TATA: -0.05 (NI 308.1m - CFO 429.4m) / TA 2.45b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of July 08, 2026, the stock is trading at USD 91.07 with a total of 445,430 shares traded. Over the past week, the price has changed by +5.47%, over one month by -5.85%, over three months by +2.38% and over the past year by -34.11%.
Current recommended Stop Loss: 86.30 (which is 5.2% or 1.3 ATR below the current price).
Stride has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy LRN.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 113.5 | 24.6% |
P/E Trailing = 13.8607
P/E Forward = 9.9502
P/S = 1.4854
P/B = 2.2939
P/EG = 0.4976
Revenue TTM = 2.54b USD
EBIT TTM = 412.8m USD
EBITDA TTM = 535.7m USD
Long Term Debt = 417.6m USD (from longTermDebt, last quarter)
Short Term Debt = 61.7m USD (from shortTermDebt, last quarter)
Debt = 677.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 129.8m
Net Debt = -128.6m USD (calculated: Debt 677.3m - CCE 805.8m)
Enterprise Value = 3.64b USD (3.77b + Debt 677.3m - CCE 805.8m)
Interest Coverage Ratio = 35.63 (Ebit TTM 412.8m / Interest Expense TTM 11.6m)
EV/FCF = 9.71x (Enterprise Value 3.64b / FCF TTM 374.8m)
FCF Yield = 10.30% (FCF TTM 374.8m / Enterprise Value 3.64b)
FCF Margin = 14.78% (FCF TTM 374.8m / Revenue TTM 2.54b)
Net Margin = 12.15% (Net Income TTM 308.1m / Revenue TTM 2.54b)
Gross Margin = 38.34% ((Revenue TTM 2.54b - Cost of Revenue TTM 1.56b) / Revenue TTM)
Gross Margin QoQ = 36.76% (prev 41.13%)
Tobins Q-Ratio = 1.49 (Enterprise Value 3.64b / Total Assets 2.45b)
Interest Expense / Debt = 1.71% (Interest Expense 11.6m / Debt 677.3m)
Taxrate = 23.16% (92.9m / 401.0m)
NOPAT = 317.2m (EBIT 412.8m * (1 - 23.16%))
Current Ratio = 6.21 (Total Current Assets 1.76b / Total Current Liabilities 283.2m)
Debt / Equity = 0.41 (Debt 677.3m / totalStockholderEquity, last quarter 1.64b)
Debt / EBITDA = -0.24 (Net Debt -128.6m / EBITDA 535.7m)
Debt / FCF = -0.34 (Net Debt -128.6m / FCF TTM 374.8m)
Total Stockholder Equity = 1.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.24% (Net Income 308.1m / Total Assets 2.45b)
RoE = 19.89% (Net Income TTM 308.1m / Total Stockholder Equity 1.55b)
RoCE = 20.99% (EBIT 412.8m / Capital Employed (Equity 1.55b + L.T.Debt 417.6m))
RoIC = 15.11% (NOPAT 317.2m / Invested Capital 2.10b)
WACC = 4.10% (E(3.77b)/V(4.44b) * Re(4.60%) + D(677.3m)/V(4.44b) * Rd(1.71%) * (1-Tc(0.23)))
Discount Rate = 4.60% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 60.0 | Cagr: 4.13%
[DCF] Terminal Value 77.97% ; FCFF base≈322.8m ; Y1≈370.1m ; Y5≈544.6m
[DCF] Fair Price = 195.7 (EV 8.20b - Net Debt -128.6m = Equity 8.32b / Shares 42.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.22 | EPS CAGR: 47.49% | SUE: 0.34 | # QB: 0
Revenue Correlation: 99.36 | Revenue CAGR: 13.66% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.50 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS current Year (2026-06-30): EPS=8.20 | Chg30d=+0.00% | Revisions=+50% | GrowthEPS=+1.2% | GrowthRev=+4.3%
EPS next Year (2027-06-30): EPS=8.76 | Chg30d=+0.00% | Revisions=-40% | GrowthEPS=+6.8% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +22% (up=4, down=2)